Clinical Trials Browser

Phase 2 × ADI PEG20 × Sarcoma × Clear all

NCT03449901 2025-12-11

ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing's Sarcoma, and Small Cell Lung Cancer

Phase 2 Completed

98 enrolled 12 charts

Sarcoma